← Browse by Condition
Medical Condition

hip fractures

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for hip fractures sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hip fractures Clinical Trials

How many clinical trials are currently recruiting for hip fractures?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for hip fractures, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hip fractures?
hip fractures research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hip fractures clinical trial?
Eligibility criteria for hip fractures trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Zimmer Biomet 1 trial
University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje 1 trial
University of Thessaly 1 trial
Beijing Jishuitan Hospital 1 trial
Zagazig University 1 trial

Recruiting Clinical Trials

NCT04028687
Recruiting

MDR - PMCF Study for Taperloc Complete Stems

Enrollment
820 pts
Location
United States
Sponsor
Zimmer Biomet
View Trial →
NCT07432737
Recruiting

One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures

Enrollment
120 pts
Location
North Macedonia
Sponsor
University Hospital for Surgic...
View Trial →
NCT05091645
Recruiting

Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture

Enrollment
89 pts
Location
Greece
Sponsor
University of Thessaly
View Trial →
NCT03461237
Recruiting

Chinese Second Hip Fracture Evaluation

Enrollment
3,000 pts
Location
China
Sponsor
Beijing Jishuitan Hospital
View Trial →
NCT05660603
Recruiting

Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery

Enrollment
63 pts
Location
Egypt
Sponsor
Zagazig University
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology